VERACYTE INC (VCYT:NASDAQ)
$50.01 -2.16 (-4.1403%)
Analysed VERACYTE INC (VCYT:NASDAQ) News Sources
Mammogen Appoints Diagnostics Industry Leader, Dr. Robert S. Epstein, to Board of Directors
13-10-2026
yahoo.com
Veracyte (VCYT) Stock Still Looks Cheap As Its 107% Run Continues
09-10-2026
yahoo.com
Veracyte to Release Third Quarter 2026 Financial Results on November 4, 2026
14-10-2026
yahoo.com
Veracyte Secures Medicare Reimbursement for Prosigna Breast Risk of Recurrence Test
16-10-2026
yahoo.com
Six Studies to Highlight Veracyte’s Genomic Tests Across Breast, Prostate and Bladder Cancer at ESMO 2026
19-10-2026
yahoo.com
Will Veracyte (VCYT) Beat Estimates Again in Its Next Earnings Report?
21-10-2026
yahoo.com
Phase III Trial Shows Veracyte’s Decipher Prostate Test Can Predict Benefit from Adding Abiraterone to Treatment in Very High-Risk Prostate Cancer
23-10-2026
yahoo.com
Clinical Trial Data Might Change The Case For Investing In Veracyte Stock (VCYT)
28-10-2026
yahoo.com
Veracyte (VCYT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
28-10-2026
yahoo.com
Veracyte to Participate in Upcoming Investor Conferences
29-10-2026
yahoo.com
What is the current price of VERACYTE INC (VCYT:NASDAQ)?
The current price of VERACYTE INC (VCYT:NASDAQ) is $50.01.
VERACYTE INC (VCYT:NASDAQ) absolute price change since previous trading day?
The absolute price change of VERACYTE INC (VCYT:NASDAQ) since the previous trading day is $-2.16.
VERACYTE INC (VCYT:NASDAQ) percentage price change since previous trading day?
The percentage price change of VERACYTE INC (VCYT:NASDAQ) since the previous trading day is -4.1403%.
What is the most recent average sentiment score for VERACYTE INC (VCYT:NASDAQ)?
The most recent average sentiment score for VERACYTE INC (VCYT:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for VERACYTE INC (VCYT:NASDAQ)?
The most recent sentiment for VERACYTE INC (VCYT:NASDAQ) is .
SEC-8K** Filing Available For VERACYTE INC (VCYT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.